- Fennec Pharmaceuticals (TSX:FRX:CA) has made partial repayment of $13 million of the approximately $32 million outstanding convertible debt facility with Petrichor Healthcare Capital Management. This early partial repayment was financed entirely with available cash.
- Post repayment, the convertible debt facility with
Fennec Pharmaceuticals partially repays its outstanding convertible debt facility (FENC:NASDAQ)
